[ad_1] Naina MishraTribune News ServiceChandigarh, April 26 PGIMER evaluated the safety of Mycobacterium w (Mw) in four hospitalized patients with COVID-19 and found no short-term adverse effects of the drug in the pre-study phase. PGIMER has planned a prospective randomized trial in Chandigarh together with AIIMS-Delhi and AIIMS-Bhopal to study …
Read More »Mw is not a vaccine for COVID-19, too early to declare its efficacy: PGIMER: The Tribune India
